34 results on '"Fajkovic, Harun"'
Search Results
2. Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder
3. Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: a systematic review and network meta-analysis
4. PD63-07 INTRAVESICAL THERAPY IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF ONCOLOGIC OUTCOMES
5. Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysis
6. Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma?
7. Critical Role of Neprilysin in Kidney Angiotensin Metabolism
8. Tubeless percutaneous nephrolithotomy
9. PD1/PD-L1 therapy in metastatic renal cell carcinoma
10. Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma
11. Enhanced Recovery after Radical Cystectomy
12. Editorial comment
13. The interaction of gender and smoking on bladder cancer risks
14. Robot-assisted partial nephrectomy
15. Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma
16. 1764 COMPARATIVE ONCOLOGIC EFFECTIVENESS BETWEEN ROBOT-ASSISTED AND OPEN RADICAL CYSTECTOMY
17. MP78-12 ASSOCIATION OF CIGARETTE SMOKING AND SMOKING CESSATION WITH BIOCHEMICAL RECURRENCE IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER
18. MP2-12 PROGNOSTIC IMPACT OF TUMOR STAGE ON POSITIVE LYMPH NODE STATUS IN UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY
19. Sex steroids and gender differences in nonmuscle invasive bladder cancer
20. Impact of ABO Blood Type on Outcomes in Patients with Primary Nonmuscle Invasive Bladder Cancer
21. MP77-05 ASSOCIATION OF PERIOPERATIVE BLOOD TRANSFUSION WITH ONCOLOGIC OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA
22. MP56-07 COMPARISON OF THE EORTC TABLES AND THE NEWLY INTRODUCED EAU CATEGORIES FOR RISK STRATIFICATION OF PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER
23. Impact of Statin Use on Oncologic Outcomes in Patients with Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy
24. 358 DOES INCREASING THE NODAL YIELD IMPROVE OUTCOMES IN PATIENTS WITHOUT NODAL METASTASIS AT RADICAL PROSTATECTOMY?
25. 1780 FEMALE GENDER IS ASSOCIATED WITH HIGHER RISK OF DISEASE RECURRENCE IN PATIENTS WITH PRIMARY T1 HIGH GRADE UROTHELIAL CARCINOMA OF THE BLADDER
26. Impact of Smoking on Outcomes of Patients with a History of Recurrent Nonmuscle Invasive Bladder Cancer
27. 391 CLINICAL UTILITY OF NMP22 FOR BLADDER CANCER SURVEILLANCE A MULTI-CENTER CROSS-SECTIONAL STUDY
28. 1904 EXTRANODAL EXTENSION IS A POWERFUL PROGNOSTIC FACTOR IN BLADDER CANCER PATIENTS WITH LYMPH NODE METASTASIS
29. 638 INTERNATIONAL VALIDATION OF THE PROGNOSTIC VALUE OF SUBCLASSIFICATION FOR AJCC STAGE PT3 UPPER TRACT UROTHELIAL CARCINOMA OF THE RENAL PELVIS
30. 392 DISEASE-FREE SURVIVAL AS A SURROGATE FOR 5-YEAR OVERALL SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA
31. 1400 CLINICAL NODAL STAGING SCORES FOR BLADDER CANCER A NEW PREOPERATIVELY NODAL ASSESSMENT TOOL
32. Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients With Upper Tract Urothelial Carcinoma
33. Risk Stratification of Organ Confined Bladder Cancer After Radical Cystectomy Using Cell Cycle Related Biomarkers
34. Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients With Upper Tract Urothelial Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.